Bluefish announces new share issue of approximately SEK 50 million
"Securing liquidity and improving the equity ratio”The board of directors for Bluefish Pharmaceuticals AB (Bluefish or the Company) has resolved to, conditional on the subsequent approval by the shareholders at the annual general meeting on 27 May 2014, carry through a new issue of shares, subject to pre-emption rights for existing shareholders. The Company’s share capital shall be increased by not more than SEK 2,837,699.80 through the issuance of not more than 14,188,499 Class B shares. Shareholders shall be entitled to subscribe for one new Class B share in respect of every five